Taken together, these results suggest that the downregulation of FXR is an effective approach for the inactivation of FXR and downregulation of its target genes, such as NF-κB and VEGF, resulting in the inhibition of invasion and metastasis of pancreatic cancer cells. This evidence concerns the gene VEGFA and familial pancreatic carcinoma.